Amundi raised its position in shares of Eli Lilly and Company.
2 reports, 1 independent
Updated Sep 10
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amundi raised its position in shares of Eli Lilly and Company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Amundi increased its holdings in Ameren stock on August 17, 2026.
- Amundi and Norges Bank increased their holdings in Johnson Controls International, while Morgan Stanley upgraded its rating.
- Amundi grew its stake in Applied Industrial Technologies on September 8, 2026.
- Eli Lilly and Company filed institutional holdings reports with the SEC, while Bank of America raised price targets on the stock.
- Amundi increased its stake in Adecoagro shares on September 2, 2026.